ArticleJournal of cancer research and clinical oncology2026
Health economic evaluation of Mirvetuximab soravtansine for the treatment of FRα-positive, platinum resistant ovarian cancer in Germany.
Franz F Janke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.